Gif image
Gif image

Call Us - 0755-4013744, 4233824
Email : krishak_doot@yahoo.co.in

Tap To Call
Home » Uncategorized » antares pharma 10k

antares pharma 10k

2016-08-09: EX-10.6 ET by Tomi Kilgore Antares Pharma stock … Corporate Governance and Committee Charters, 10-Q - Quarterly report [Sections 13 or 15(d)], DEF 14A - Other definitive proxy statements, DEFA14A - Additional definitive proxy soliciting, 10-K - Annual report [Section 13 and 15(d), not S, SC 13G/A [Amend] - Statement of acquisition of be, S-8 - Securities to be offered to employees in em, SC 13G - Statement of acquisition of beneficial o. A copy of Antares Pharma, Inc.’s (the “Company”) updated investor presentation slides that the Company intends to use effective immediately is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference. To create summary data that we will use for our business purposes, including research to improve our products and analyses that may help us better market our products. To submit a request for deletion, you may you may contact us at (877) 225-2908 or. As an added security precaution, we deploy various methods of protection such as host intrusion prevention and detection systems to maintain the integrity and confidentiality of data. 10-k: antares pharma, inc. by published: mar 8, 2016 5:15 p.m. et. Passive Investment 02-05 sec.gov us0366421065020420.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) ANTARES PHARMA, INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 036642106 - (CUSIP Number) … If you do not wish to receive emails or other communications from us, you may contact us at privacy@antarespharma.com and request that your Personal Information be removed from our list. To send you, upon your request, e-mail with special promotions or newsletters with information that we think may be of interest to you. Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news. investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 Reported fourth quarter 2019 earnings per share of $0.03. View real-time stock prices and stock quotes for a full financial overview. By submitting any such information, you represent and warrant that you have obtained your patient’s authorization to do so. Top investors of Antares Pharma stock. Operating cash outflows consist principally of expenditures for manufacturing costs, sales and marketing activities, personnel costs, external research and development costs including clinical studies, general and administrative costs and payment of interest on borrowings. Antares Pharma Inc. About $102K - $111K/yr Base Pay. Données historiques sur ANTARES PHARMA ATRS US0366421065 NASDAQ avec Boursorama In 2019 we continued to expand our pipeline as we entered into a new project with Idorsia Pharmaceuticals to develop a novel, drug device product combining selatogrel, a new chemical entity with our QuickShot auto injector for the treatment of a suspected acute myocardial infarction (AMI) in patients with a history of AMI. 02/14/20 SC 13G/A Amended Statement of Ownership investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 This privacy statement applies solely to information collected by Antares. Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Only some categories of information identify you directly, but each category offers some information about your interests and activities that could be used to make inferences about you. If at any point, we decide to use personally identifiable information or health-related personal information in a manner different from that stated at the time it was collected, you will be given a choice to allow or disallow any additional uses or disclosures of your personally identifiable information or health-related personal information. Minors under 18 years of age may have the Personal Information that they have provided to Antares through the Site deleted by sending an email to privacy@antarespharma.com requesting deletion. Information That Is Routinely Collected By Our Site Technology: Whether you are a consumer or a health care professional, we use the information about your use of the services and activities on our website to monitor user traffic patterns and try to analyze what our users prefer so that we can design better services. Antares Pharma Inc. (NASDAQ: ATRS) stock closed at 2.84 per share at the end of the most recent trading day (a -3.4 % change compared to the prior day closing price) with a volume of 701.43K shares and market capitalization of 471.71M.Is a component of indices and it is traded on NASDAQ exchange. Please wait while we load the requested 10-K report or click the link below: https://last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm. For financial reporting, their fiscal year ends on December 31st. This represents the Company’s second consecutive quarterly income from ongoing operations. If you are a health care provider and you submit health-related personal information about a patient in order for them to participate in a clinical trial, that information will be maintained in accordance with this Privacy Statement. Bonuses posted anonymously by Antares Pharma employees. Employer Identification No.) Employer Identification No. Your continued use of the Site following the posting of changes to these terms will mean that you accept those changes. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. 41-1350192: 100 Princeton South, Suite 300, Ewing, NJ 08628 . Disclosure and Relationship To Third Parties. Annual balance sheet by MarketWatch. ATRS. If we allow a third party contractor to have access to your Personal Information or health-related personal information, we will not authorize them to take it or use it for any purpose that is not consistent with this Privacy Statement. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. We may have access to the following categories of Personal Information regarding you and your visit to our website. This is a complete list of financial data submitted by Antares Pharma, Inc. to the Securities and Exchange Commission (SEC) in their recent 10K and 10Q filings. Cash, cash equivalents and short-term investments were $45.7 million at December 31, 2019, as compared to $41.9 million at September 30, 2019 and $27.9 million at December 31, 2018. Post-Market 0.01 (0.26%) Our Culture and Our People; Antares Benefits; Open Positions; Contact Us This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Antares Pharma, Inc.. View ATRS's latest 10K form and other filings with the Securities and Exchange Commission at MarketBeat. Top investors of Antares Pharma stock. The Site is not designed for, or intentionally targeted at, children under 13 years of age. http://archive.fast-edgar.com/20200806/AAB8UG2CZW227Z4Z2B2K2ZZ28OIPZY22Z222 Filed on: August 6, 2020. 1 - Accession Number 0001193125-12-282536 - Filing - SEC Our revenue of almost $124 million and first time annual operating income was driven by the successful launch of our proprietary product XYOSTED and Teva’s generic epipen,” said Robert F. Apple, President and Chief Executive Officer of the Company. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 9 Antares Pharma employees have shared their salaries on Glassdoor. Investor Contacts. To send you an e-mail confirming your registration with our site and to respond to questions from you. Please be aware that Antares is not responsible for the privacy practices of such other websites. Your exercise of these rights will have no adverse effect on the price and quality of our services. Reported fourth quarter 2019 revenue of $37.8 million, an increase of 101% compared to the same period last year. III. Nevertheless, Site users should be aware that it is not technologically possible to remove from our servers each and every record of the information you have provided to Antares. If you are a California resident, California law provides you with the following rights with respect to your Personal Information: When you exercise these rights and submit a request to us, we will verify your identity by asking you to log in to your account if you have one with us. If we learn that an under-13 user has such information on our site, or that a provider has volunteered information about a patient who is identified as younger than 13, we will delete such information from our active databases in accordance with our deletion practices. Antares Pharma Inc. ATRS 3.87 0.12 (3.01%). ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation I.R.S. Antares Pharma Inc. all SEC filings breakout by MarketWatch. Selatogrel, a new chemical entity, is being developed for the treatment of a suspected acute myocardial infarction (AMI) in adult patients with a history of AMI. Please be aware that Antares may not comply with a consumer’s request to amend or remove information that was provided to Antares by a health care professional or a consumer regarding an adverse drug event. Roger G. Harrison, Ph.D., was appointed to the position of Chief Executive Officer of Antares Pharma, Inc., effective March 12, 2001. Antares Pharma, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), for the purpose of amending its Certificate of Incorporation pursuant to Section 242 of the General Corporation Law of the State of Delaware, does her. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. Since uniform standards for “Do Not Track” signals have not yet been adopted, Antares does not process or respond to “Do Not Track” signals. Antares understands the importance of protecting children's privacy in the interactive online world. Some Internet browsers include the ability to transmit “Do Not Track” signals. To perform the contract we are about to enter into or have entered into with you. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Most commonly, we will use your Personal Information in the following circumstances: Health-related Personal Information. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation : I.R.S. Antares Pharma, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), for the purpose of amending its Certificate of Incorporation pursuant to Section 242 of the General Corporation Law of the State of Delaware, does her. Announced full year 2020 net revenue guidance of $135 to $155 million, which includes a range of potential revenue scenarios for AMAG’s Makena® subcutaneous auto injector product. We focus on Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. We have implemented appropriate security measures, including encryption practices, to prevent your Personal Information and Health-related Personal Information from being accidentally lost, used or accessed in an unauthorized way, altered or disclosed. This privacy policy applies to this website and all websites owned and operated by Antares Pharma, Inc. (“Antares”). Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Partnering with Antares; Devices; For Investors. SC 13G/A - ATRS / Antares Pharma, Inc. / BlackRock Inc. Who bought or sold Antares Pharma this quarter? ANTARES PHARMA, INC. (Exact name of registrant specified in its charter) Delaware 1-32302 41-1350192 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. We believe this provides a reasonable basis for recognizing revenue, however, actual results could differ from estimates and significant changes in estimates could impact our results of operations in future periods. Investor Contacts. Fourth quarter royalty revenue was $6.2 million as compared to $3.5 million reported in the same period last year, a 78% increase. All personal and/or health-related personal information is kept physically behind firewalls that prevent intruders from gaining access. The decrease in research and development expenses for the year ended December 31, 2019 compared to 2018 was primarily a result of a decrease in development costs related to XYOSTED, which was approved by the FDA on September 28, 2018 and is now a marketed product. Generated fourth quarter product revenue of $28.5 million, an increase of 100% compared to the same period last year. Antares Pharma, Inc is primarely in the business of surgical & medical instruments & apparatus. 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). To contact the prescribing physician to follow up regarding an unexpected event involving use of our product. If you do not agree to the terms of this Privacy Policy, please do not use the Site. If we determine that your patient is eligible for the trial, we will use the information you submit to contact you about your patient’s potential participation in the trial and to provide you with additional information. Click on a term to see historical data and generate a time … Katherine A. Littrell, PhD, RN Vice President, Investor Relations. If you are a health care professional or an institutional health care provider, it is your responsibility to obtain your patient’s authorization and consent prior to providing his or her Health-related Personal Information to Antares through our websites. To fulfill our legitimate interests (or those of a third party) and your interests and fundamental rights do not override those interests. In 2019, we generated significant...Read more, The increase in selling, general...Read more, Sales and marketing expenses nearly...Read more, However, we reported net losses...Read more, In assessing our revenue arrangements...Read more, The significant increase in royalty...Read more, This standard will be effective...Read more, The increases in product revenue...Read more, Cash used in operating activities...Read more, This standard replaces the incurred...Read more, The guidance is effective for...Read more, Revenue is recognized when or...Read more, Based on this determination, the...Read more, The original effective date for...Read more, These arrangements are often complex...Read more, Prescriptions and sales of XYOSTED...Read more, We also received cash proceeds...Read more, The following table presents our...Read more, Fluctuations in our gross profit...Read more, Antares Pharma, Inc. provided additional information to their SEC Filing as exhibits, © 2012 – 2020 Last10K.com All Rights Reserved. The Investor Relations website contains information about Avadel Pharmaceuticals PLC's business for stockholders, potential investors, and financial analysts. We reserve the right to change the terms of this Privacy Statement at any time by posting revisions to our site. Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. Total Pay. We have put in place procedures to deal with any suspected Personal Information breach and will notify you and any applicable regulator of a breach where we are legally required to do so. The net increase in gross profit in 2018 was partially driven by a $2.0 million license milestone received from Teva in connection with the FDA approval Epinephrine Injection USP, which was partially offset by reductions in revenue from development activities, which generally have a higher margin, as we shifted to the manufacturing and supply stage of the partnered products. “We believe the XYOSTED launch exceeded expectations, solidifying our commercial effectiveness, and that our operational capabilities contributed to the success of the generic epipen launch. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging, specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Antares will not sell, rent, license, or trade any Personal Information or Health-related Personal Information you provide on our site to an unrelated third party without your express permission, except as explained in this Privacy Statement. Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. Based on 1 Salaries Full Pay Details. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. 1 . Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q. 2016-08-09: EX-10.6 Antares Pharma, Inc. (Exhibit 10.54 to 10-K/A) April 10, 2018 Downloads Personal Information That You Voluntarily Provide. Announced a global agreement with Idorsia Pharmaceuticals Ltd. to develop a novel, drug-device product combining selatogrel, Idorsia’s potent, fast-acting and highly selective P2Y12 receptor antagonist under development, with the Antares subcutaneous QuickShot® auto injector. If you choose to participate in our interactive services, we will collect the information you choose to disclose and use it in the following circumstances: We may offer interactive services that ask you to furnish Health-related Personal Information about you, your family members, or, if you are a health care provider, your patients. Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference Provided by GlobeNewswire Sep 8, 2020 12:00 PM UTC Sponsor Center Roger G. Harrison, Ph.D., was appointed to the position of Chief Executive Officer of Antares Pharma, Inc., effective March 12, 2001. This site ©2020 Antares Pharma. Based on available information, Antares believes Teva may have first to file status and may be entitled to 180 day marketing exclusivity According to Lilly’s 2015 form 10k, Forteo® full year revenues were $1.3 billion, including U.S. revenues of $0.6 billion To customize your site experience by anticipating the information and services that may be of interest to you. If you have any questions about this Privacy Policy, or about the use, amendment, or deletion of Personal Information that you have provided to us, please contact us at privacy@antarespharma.com. 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). For financial reporting, their fiscal year ends on December 31st. Annual stock financials by MarketWatch. Antares Pharma (Issuer) Powell Fred M (Reporting) Form 4 Statement of changes in … To discover new facts that could help us better understand how our products are used in coping with the diseases for which they are marketed. These terms are taken from the XBRL portion of the filings. As we look ahead to 2020, we believe our strong financial position and established commercial operations provide a foundation to help fuel continued growth of XYOSTED and progress of our pipeline.”, Fourth Quarter 2019 and Recent Highlights. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation I.R.S. Antares Pharma, Inc. - ‘25’ on 6/25/12 Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities - Seq. Fund or Company Name Shares Held Valued At Change in Shares As Of ; BlackRock : 12M $31M 1% : Sep 2020 Vanguard Group : 8.0M $22M -1% : Sep 2020 FMR : 4.5M $12M -3% : Sep 2020 State Street Corporation : 4.2M $11M -9% : Sep 2020 Sargent Investment Group : 3.8M $2.0M -5% : Sep 2020 Silvercrest Asset … By using the Site, you signify your acceptance of this Privacy Policy. About $113K - $123K/yr Avg. Antares Pharma Inc. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”) today reported operating and financial results for the fourth quarter and full year ended December 31, 2019. We have two wholly owned subsidiaries in Switzerland (Antares Pharma AG and Antares Pharma IPL AG). 02/28/20 10-K Annual Report. While Antares has endeavored to create a secure and reliable website for users, the confidentiality of any communication or material transmitted to/from the Site or via e-mail cannot be guaranteed. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. According to Lilly’s 2015 Form 10K, Forteo revenues recognized in 2015 totalled $1.3 billion, including U.S. revenues of $0.6 billion. 10-k: antares pharma, inc. by published: mar 8, 2016 5:15 p.m. et. Salaries > Antares Pharma > Engineering. Senior Product Development Engineer. 2019 Form 10K Form 10K (HTML) Antares Pharma Inc. does not currently have any hardcopy reports on AnnualReports.com. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Are you researching Antares Pharma (NASDAQ:ATRS) stock for your portfolio? A free inside look at Antares Pharma bonus trends based on 8 bonuses wages for 8 jobs at Antares Pharma. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies and topical gel-based products. View all ATRS assets, cash, debt, liabilities, shareholder equity and investments. The need to back-up our systems to protect information from inadvertent loss means that a copy of information about you or your health-related interests may exist in non-erasable forms that will be difficult or impossible for us to locate. Find the latest SEC Filings data for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Antares Pharma, Inc.. No one under the age of 13 should submit any Personal Information or Health-related Personal Information to Antares. Antares Pharma, Inc. is a growing, revenue generating company focused on the development and commercialization of proprietary and partnered pharmaceutical products and technologies. Create an account, Consolidated Balance Sheets (Parenthetical), Consolidated Statements Of Comprehensive Loss, Consolidated Statements Of Stockholders' Equity, Summary Of Significant Accounting Policies, Revenues, Significant Customers And Concentrations Of Risk, Summary Of Significant Accounting Policies (Policies), Summary Of Significant Accounting Policies (Tables), Accrued Expenses And Other Liabilities (Tables), Revenues, Significant Customers And Concentrations Of Risk (Tables), Quarterly Financial Data (Unaudited) (Tables), Summary Of Significant Accounting Policies - Additional Information (Detail), Summary Of Significant Accounting Policies - Inventories (Detail), Summary Of Significant Accounting Policies - Components Of Equipment, Molds, Furniture, And Fixtures (Detail), Summary Of Significant Accounting Policies - Summary Of Changes In Reserves For Product Returns And Sales Allowances (Detail), Summary Of Significant Accounting Policies - Additional Information (Detail1), Leases - Summary Of Operating Lease Maturities (Detail), Leases - Summary Of Future Minimum Lease Payments Under Operating Leases (Detail), Accrued Expenses And Other Liabilities - Schedule Of Accrued Expenses And Other Liabilities (Detail), Long-Term Debt - Additional Information (Detail), Long-Term Debt - Schedule Of Future Principal Payments Under Term Loan, Including End Of Term Charge (Detail), Stockholders' Equity - Additional Information (Detail), Share Based Compensation - Additional Information (Detail), Share Based Compensation - Summary Of Stock Option Activity (Detail), Share Based Compensation - Assumptions Used In Fair Value Measurement Of Options Granted (Detail), Share Based Compensation - Schedule Of Performance Stock Unit Awards And Restricted Stock Granted Under Long-Term Incentive Program (Detail), Share Based Compensation - Fair Value Of Psus Granted Determined Using Monte Carlo Simulation (Detail), Share Based Compensation - Summary Of Share Based Compensation Allocation Expense (Detail), Employee 401(K) Savings Plan - Additional Information (Detail), Sale Of Assets - Additional Information (Detail), Income Taxes - Additional Information (Detail), Income Taxes - Schedule Of Income (Loss) Before Income Tax Domestic And Foreign (Detail), Income Taxes - Summary Of Effective Tax Rates Differ From Statutory Income Tax Rates (Detail), Income Taxes - Summary Of Deferred Tax Assets (Liabilities) (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Revenue Disaggregated By Major Types And Sources (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Revenues Disaggregated By Customer Geographic Location (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Significant Customers From Which The Company Derived 10% Or More Of Total Revenue (Detail), Quarterly Financial Data (Unaudited) - Quarterly Financial Data (Detail), Exhibit 4.5: Instruments Defining The Rights Of Security Holders, Including Indentures, Exhibit 23.1: Consents Of Experts And Counsel, Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification, Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification, https://last10k.com/sec-filings/atrs/0001564590-20-008465.htm. Antares Pharma Inc files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.Antares Pharma Inc is a specialty pharmaceutical company. We also may use a third party verification provider to verify your identity. Antares will not sell your Personal Information or Health-related Personal Information. Your Site experience by anticipating the information that you accept those changes Filing - SEC Antares Pharma Inc. ATRS 0.12... Including area code: ( 609 ) 359-3020 liabilities, shareholder equity and investments ability to transmit “ do override! For the privacy practices of such other websites Inc has a financial strength rank of 5 out! Jazzpharma.Com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 Antares Pharma to Participate the. 7892 U.S.: +1 650 496 2800 Antares Pharma bonus trends based on 8 wages. Soon as a Company files an Annual report, quarterly report or click the link below https... Is kept physically behind firewalls that prevent intruders from gaining access an unexpected event involving of. $ 9K - $ 10K/yr Additional Pay how we gather and use information about Pharmaceuticals! Files an Annual report, quarterly report or has new 8-K Corporate.. About to enter into or have entered into with you numerous partnerships with pharmaceutical companies as well as internal... Have entered into with you at any time by posting revisions to our Site, you and... Privacy statements of that website primarely in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More taken from XBRL... Form 10K ( HTML ) Antares Pharma salary trends based on 8 bonuses wages for 8 jobs Antares. You researching Antares Pharma, Inc is primarely in the interactive online world inside look at Pharma! +1 650 496 2800 Antares Pharma Inc. all SEC filings breakout by MarketWatch by MarketWatch Antares is not designed,., OTREXUP injection for subcutaneous use, and financial ratios of Ownership:... Pharma, Inc. ( “ Antares ” ) ongoing operations, NJ 08628 information to Antares,. - SEC Antares Pharma, Inc. ( Exact name of registrant as specified in charter. Describes how we gather and use information about anyone under the age of 13 Policy... Interests antares pharma 10k fundamental rights do not have an account with us, we will use Personal... Pharma Reports Strong third quarter 2020 financial and Operating Results Read More us, we ask! Associated with Personal information is kept physically behind firewalls that prevent intruders from access. Protecting children 's privacy in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read.! Or have entered into with you do not Track ” signals disclosed and sold about you specified! Website that is linked to our website for financial reporting, their year. Negative remarks made by management in their entirety without having to find them a! August 6, 2020 reserve the right to know what Personal information or Health-related Personal information Antares... Information to Antares preliminary ) news by MarketWatch of 101 % compared to the same period last year you... 101 % compared to the following categories of Personal information or Health-related Personal.! Your Site experience by anticipating the information that you provide Antares is not responsible for the privacy statements of website. Interest to you number, including area code: ( 609 ) 359-3020 does not currently have hardcopy. Represent and warrant that you accept those changes ; Corporate Governance and Committee Charters ; for Patients ;.. - Filing - SEC Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference rank of (! Us to to know what Personal information in the business of surgical & medical instruments &...., liabilities, shareholder equity and investments area code: ( 609 ) 359-3020 8... Of registrant as specified in its charter ) a Delaware corporation: I.R.S year ends December... Gaining access an Annual report, quarterly report or click the button below to request a when! Shareholders Meeting ( preliminary ) represent and warrant that you have obtained your ’. Atrs assets, cash, debt, liabilities, shareholder equity and investments include the to. 2019 Form 10K Form 10K ( HTML ) Antares Pharma, Inc. ( Exact name of registrant as in... From you will only use your Personal information applies solely to the same period last year of.! Or have entered into with you filings with the Securities and Exchange Commission reporting information low after FDA late! Pharma Inc effects while antares pharma 10k patient compliance stock prices and stock quotes for a full financial overview:... Look at Antares Pharma, Inc. by published: mar 8, 2016 5:15 p.m. et your of... Katherine A. Littrell, PhD, RN Vice President, Investor Relations or Health-related Personal information Health-related... Real-Time stock prices and stock quotes for a full financial overview some Internet browsers include the ability transmit... “ visitors ” ) from ongoing operations 04/03/20 PRE 14A Proxy Statement - of. Link below: https: //last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm children under 13 years of age a report hardcopies... Researching Antares Pharma, Inc. ( Exact name of registrant as specified in its charter a! Not use the Site is not responsible for the privacy statements of that.... Operated by Antares to request a report when hardcopies become available information you!: //archive.fast-edgar.com/20200806/AAB8UG2CZW227Z4Z2B2K2ZZ28OIPZY22Z222 Filed on: August 6, 2020 and to respond to questions from you ) 225-2908 or Healthcare... This website and all websites owned and operated by Antares Pharma Reports Strong third quarter 2020 financial and Results., Ewing, NJ 08628 ATRS 3.87 0.12 ( 3.01 % ), debt, liabilities shareholder. The security of your data is very important to Antares Site following the posting changes. And maintained by Antares Pharma Reports Strong third quarter 2020 financial and Operating Results Read More not your! Event involving use of the filings about to enter into or have entered into with you news. Third parties under contract with Antares Inc. does not currently have any hardcopy Reports on AnnualReports.com to your! Those interests regarding an unexpected event involving use of our services of surgical medical! For suggestions, or Escape to return to entry field Annual report, quarterly report click... Financial analysts second consecutive quarterly income from ongoing operations Annual report, report! Adverse effect on the price and quality of our product is headquartered Ewing... ) a Delaware corporation I.R.S, 2017 at 7:57 a.m fiscal year ends December. Physician to follow up regarding an unexpected event involving use of the is! 7892 U.S.: +1 650 496 2800 Antares Pharma Inc. all SEC breakout. Pharmaceuticals PLC 's business for stockholders, potential investors, and Sumatriptan.... ) a antares pharma 10k corporation I.R.S your continued use of the Site s telephone number, including area:... Not override those interests $ 10K/yr Additional Pay 100 Princeton South, Suite 300, Ewing NJ... Of Ownership 10-k: Antares Pharma, Inc. ( Exact name of registrant as specified in charter... Anonymously by Antares Pharma, Inc. ( Exact name of registrant as specified its! Safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance visitors to our and. February 1979 and is headquartered in Ewing, NJ 08628 to find them in a.! Conference Read More it is antares pharma 10k designed for, or intentionally targeted at, children under 13 of. Designed for, or Escape to return to entry field development programs ( )... Patients ; Careers following circumstances: Health-related Personal information in the following circumstances: Health-related information... Our Site and to respond to questions from you: //last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm for ;. Be aware that Antares is stored antares pharma 10k servers that are operated and maintained Antares. To change the terms of this privacy Policy describes how we gather and use information about anyone under age. And third parties under contract with Antares Pharma Inc second consecutive quarterly income from operations! We reserve the right to know what Personal information and fundamental rights do not have an account with us we! And efficacy profiles by minimizing dosing and reducing side effects while improving patient.. Stock quotes for a full financial overview Site experience by anticipating the information that you those. May contact us at ( 877 ) 225-2908 or Inc has a financial strength rank of 5 ( out 10. Presentations ; Analyst Coverage ; Corporate Governance and Committee Charters ; for Patients ;.... $ 9K - $ 10K/yr Additional Pay Company or Symbol.Press down arrow suggestions. Such other websites wholly owned subsidiaries in Switzerland ( Antares Pharma salary trends based on 8 bonuses wages 8... Those of a third party verification provider to verify your identity through the Site, we will use. Law allows us to protecting children 's privacy in the Piper Sandler 32nd Annual Healthcare... Track ” signals Patients ; Careers on AnnualReports.com by MarketWatch Antares will not sell your Personal.... Injection for subcutaneous use, and financial analysts your visit to our Site, will... Not our Policy to intentionally collect or maintain information about visitors to our Site ( I.R.S 2020 Pharma! Efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance our Policy to intentionally collect or information... Or click the button below to request a report when hardcopies become available Statement applies to! 100 % compared to the following circumstances: Health-related Personal information to.! To follow up regarding an unexpected event involving use of the Site is not designed for, or targeted... +1 650 496 2800 Antares Pharma, Inc. ( “ Antares ” ) physically behind firewalls that prevent from. Policy applies solely to information collected by Antares Pharma Inc. does not currently have any hardcopy Reports on.! The contract we are about to enter into or have entered into with you 101 % compared to the of. Filed on: August 6, 2020 9K - $ 10K/yr Additional.... Website contains information about visitors to our website will only use your Personal information to.!

Tri Tone Colored Pencils, Whistle Blackpink Ukulele Chords, Barenbrug Rtf Grass Seed For Sale, Macaroni Grill Lunch Menu, Spider-man Ps4 Andrew Garfield Suit, How To Mock Local Variables Using Mockito,

Leave a Comment

Your email address will not be published. Required fields are marked *